Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Natural Product Reports | journal | 3.169 Q1 | 211 | 39 | 132 | 6176 | 988 | 128 | 6.70 | 158.36 | |
2 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | |
3 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
4 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.009 Q1 | 99 | 12 | 40 | 1342 | 143 | 39 | 3.47 | 111.83 | |
5 | Critical Reviews in Toxicology | journal | 1.850 Q1 | 129 | 36 | 49 | 3985 | 298 | 47 | 5.45 | 110.69 | |
6 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | ||
7 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | |
8 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
9 | Expert Opinion on Drug Delivery | journal | 0.372 Q2 | 133 | 81 | 16 | 7108 | 25 | 14 | 1.56 | 87.75 | |
10 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | |
11 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | |
12 | Clinical Pharmacokinetics | journal | 1.745 Q1 | 184 | 86 | 248 | 6300 | 1723 | 245 | 7.12 | 73.26 | |
13 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 82 | 240 | 5937 | 592 | 220 | 2.60 | 72.40 | |
14 | Drug Safety | journal | 1.053 Q1 | 140 | 86 | 272 | 5982 | 1158 | 258 | 4.11 | 69.56 | |
15 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 242 | 594 | 16676 | 1479 | 582 | 2.47 | 68.91 | |
16 | Particle and Fibre Toxicology | journal | 0.487 Q3 | 119 | 11 | 3 | 752 | 3 | 2 | 1.00 | 68.36 | |
17 | Molecular Diagnosis and Therapy | journal | 68 | 61 | 161 | 4159 | 452 | 159 | 2.90 | 68.18 | ||
18 | Toxicological Reviews | journal | 0.737 Q2 | 49 | 29 | 46 | 1862 | 109 | 45 | 2.37 | 64.21 | |
19 | Current Opinion in Investigational Drugs | journal | 0.921 Q2 | 83 | 148 | 571 | 8853 | 1617 | 531 | 3.06 | 59.82 | |
20 | Neuropsychopharmacology | journal | 2.583 Q1 | 249 | 238 | 727 | 13808 | 4232 | 688 | 5.53 | 58.02 | |
21 | Expert Opinion on Therapeutic Patents | journal | 0.550 Q2 | 88 | 120 | 374 | 6911 | 539 | 361 | 1.36 | 57.59 | |
22 | Journal of Liposome Research | journal | 0.478 Q2 | 64 | 15 | 73 | 852 | 127 | 70 | 1.05 | 56.80 | |
23 | Toxin Reviews | journal | 0.253 Q3 | 54 | 24 | 86 | 1359 | 64 | 77 | 0.74 | 56.63 | |
24 | Journal of Immune Based Therapies and Vaccines | journal | 1.060 Q1 | 21 | 7 | 14 | 365 | 29 | 13 | 2.07 | 52.14 | |
25 | Antiviral Chemistry and Chemotherapy | journal | 0.555 Q2 | 59 | 36 | 102 | 1871 | 190 | 101 | 2.01 | 51.97 | |
26 | Trends in Pharmacological Sciences | journal | 4.267 Q1 | 244 | 106 | 404 | 5469 | 3362 | 340 | 9.18 | 51.59 | |
27 | Toxicology Mechanisms and Methods | journal | 0.175 Q4 | 55 | 46 | 108 | 2359 | 74 | 106 | 0.75 | 51.28 | |
28 | Current Opinion in Molecular Therapeutics | journal | 1.121 Q1 | 67 | 82 | 268 | 4057 | 793 | 242 | 2.85 | 49.48 | |
29 | Current Opinion in Drug Discovery and Development | journal | 1.278 Q1 | 85 | 73 | 265 | 3560 | 1024 | 250 | 4.18 | 48.77 | |
30 | Mutagenesis | journal | 0.684 Q2 | 102 | 59 | 225 | 2865 | 552 | 220 | 2.16 | 48.56 | |
31 | Neuropharmacology | journal | 2.034 Q1 | 191 | 250 | 728 | 11590 | 3108 | 727 | 4.07 | 46.36 | |
32 | Pharmacogenomics | journal | 0.886 Q2 | 100 | 89 | 277 | 4121 | 787 | 240 | 2.68 | 46.30 | |
33 | Food and Chemical Toxicology | journal | 0.897 Q2 | 203 | 161 | 578 | 7361 | 1612 | 564 | 2.43 | 45.72 | |
34 | Tetrahedron | journal | 1.375 Q1 | 236 | 1219 | 3383 | 54820 | 9974 | 3365 | 2.88 | 44.97 | |
35 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.584 Q2 | 67 | 76 | 202 | 3363 | 254 | 194 | 1.20 | 44.25 | |
36 | Toxicological Sciences | journal | 1.276 Q1 | 207 | 320 | 831 | 14102 | 3138 | 796 | 3.26 | 44.07 | |
37 | Inhalation Toxicology | journal | 0.895 Q2 | 97 | 76 | 256 | 3304 | 649 | 252 | 2.50 | 43.47 | |
38 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 77 | 213 | 3234 | 456 | 211 | 2.17 | 42.00 | |
39 | Environmental Pollution | journal | 1.510 Q1 | 301 | 326 | 870 | 13322 | 2505 | 863 | 2.78 | 40.87 | |
40 | Pharmacogenomics Journal | journal | 1.395 Q1 | 95 | 45 | 176 | 1837 | 690 | 149 | 3.66 | 40.82 | |
41 | International Journal of Neuropsychopharmacology | journal | 1.337 Q1 | 125 | 73 | 175 | 2974 | 612 | 152 | 3.21 | 40.74 | |
42 | PharmacoEconomics | journal | 0.904 Q2 | 118 | 110 | 331 | 4430 | 910 | 312 | 2.64 | 40.27 | |
43 | Journal of Peptide Science | journal | 0.615 Q2 | 73 | 99 | 217 | 3950 | 344 | 210 | 1.71 | 39.90 | |
44 | Drug Discovery Today: Disease Models | journal | 0.130 Q4 | 33 | 48 | 64 | 1909 | 8 | 64 | 0.13 | 39.77 | |
45 | Drug Discovery Today: Disease Mechanisms | journal | 0.156 Q4 | 28 | 81 | 65 | 3216 | 19 | 64 | 0.29 | 39.70 | |
46 | Human Genomics | journal | 1.921 Q1 | 68 | 22 | 43 | 868 | 117 | 42 | 2.72 | 39.45 | |
47 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.101 Q4 | 8 | 14 | 17 | 548 | 0 | 16 | 0.00 | 39.14 | |
48 | Clinical and Experimental Pharmacology and Physiology | journal | 0.688 Q2 | 115 | 177 | 526 | 6919 | 969 | 517 | 1.59 | 39.09 | |
49 | Journal of Psychopharmacology | journal | 0.956 Q1 | 135 | 120 | 218 | 4648 | 617 | 194 | 2.95 | 38.73 | |
50 | Antiviral Therapy | journal | 1.694 Q1 | 93 | 127 | 241 | 4818 | 931 | 229 | 4.12 | 37.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®